This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Addition of Risperidone to Clozapine Therapy in Chronically Psychotic Inpatients

Izaäk W. de Groot, Adolph H. Heck, and Peter N. van Harten

Published: February 2, 2001

Article Abstract

Letter to the Editor

Sir: Patients with schizophrenia who remain severely psychotic despite several courses of treatment with classical antipsychotics and clozapine constitute a major problem in clinical practice. One 4-week open trial, reported by Henderson and Goff, showed that augmentation of clozapine with risperidone produced at least a 20% reduction on the Brief Psychiatric Rating Scale (BPRS) in 10 of 12 schizophrenic outpatients with persistent psychotic symptoms.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 62

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Clinical and Practical Psychopharmacology

Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in...

Read More...